Danaher Corp

DHR: XNYS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|^qLOCK|@j?LOCK|y%>VQRF

Danaher Earnings: Outlook Just Steady, Even as Strength in Biotech Segment and Margins Boosts Profit

On April 21, Danaher reported first-quarter results, including adjusted EPS growth of nearly 10%, exceeding prior expectations despite core revenue growth of only 0.5%. With that profit strength, management raised the top end of its 2026 adjusted EPS outlook range by a nickel to $8.35-$8.55.

Sponsor Center